trending Market Intelligence /marketintelligence/en/news-insights/trending/oimyryhryiv9evmlnz1zdg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Mersana adds former Amgen exec to board

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Mersana adds former Amgen exec to board

Cambridge, Mass.-based Mersana Therapeutics Inc. appointed Willard Dere as an independent director of the company.

Dere, who is a professor at the University of Utah Health Sciences Center, has over three decades of research, clinical and regulatory biopharmaceutical leadership experience. He is the former chief medical officer of Amgen and has also served Eli Lilly and Co. in a number of leadership positions, Mersana said in a statement.